'We can't find markers evidence'
Contract negotiators delivered bad news on the quality and outcomes framework to delegates at a major clinical meeting last week.
Speaking at the National Institute for Clinical Excellence annual meeting in Birmingham, the negotiators said cancer, rheumatoid arthritis and osteoporosis had been dropped as tiered clinical markers because of lack of primary care evidence.
GPC negotiator Dr Laurence Buckman said the tiered clinical markers would include epilepsy, hypothyroidism, chronic obstructive pulmonary disease, asthma and possibly mental health and learning difficulties. Cancer will now be an organisational marker.
NHS Confederation negotiator Dr Tony Snell said they had 'struggled' to find relevant primary care elements in the evidence.